These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12050592)

  • 21. Foundation Review: Transgenic animals and their impact on the drug discovery industry.
    Dunn DA; Pinkert CA; Kooyman DL
    Drug Discov Today; 2005 Jun; 10(11):757-67. PubMed ID: 15922934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 23. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 24. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 25. Life beyond synthesis.
    Russo E
    Nature; 2003 Jul; 424(6948):594-6. PubMed ID: 12891371
    [No Abstract]   [Full Text] [Related]  

  • 26. The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena.
    Ramanathan R; Korfmacher W
    Bioanalysis; 2012 Mar; 4(5):467-9. PubMed ID: 22409544
    [No Abstract]   [Full Text] [Related]  

  • 27. Compound scale-up at the discovery-development interface.
    Nikitenko AA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Success in an uneven market.
    Russo E
    Nature; 2003 Jul; 424(6948):597. PubMed ID: 12891372
    [No Abstract]   [Full Text] [Related]  

  • 29. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
    Fitzgerald GA
    Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role of analytical chemistry in the pharmacy of the 21st Century].
    Görög S
    Acta Pharm Hung; 2001 Oct; 71(3):337-43. PubMed ID: 11961903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural products to drugs: natural product-derived compounds in clinical trials.
    Butler MS
    Nat Prod Rep; 2008 Jun; 25(3):475-516. PubMed ID: 18497896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Embedding sustainable practices into pharmaceutical R&D: what are the challenges?
    Sneddon H
    Future Med Chem; 2014; 6(12):1373-6. PubMed ID: 25329193
    [No Abstract]   [Full Text] [Related]  

  • 33. Facts, figures and trends in lead generation.
    Deprez-Poulain R; Deprez B
    Curr Top Med Chem; 2004; 4(6):569-80. PubMed ID: 14965294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
    Edwards PJ; Allart B; Andrews MJ; Clase JA; Menet C
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):425-44. PubMed ID: 16889227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yin and Yang in medicinal chemistry: what does drug-likeness mean?
    Macarrón R; Luengo JI
    Future Med Chem; 2011 Apr; 3(5):505-7. PubMed ID: 21526891
    [No Abstract]   [Full Text] [Related]  

  • 36. Michael Hanson.
    Hanson M
    Nat Rev Drug Discov; 2016 Feb; 15(2):80. PubMed ID: 26837587
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of continuous pharmaceutical production processes supported by process systems engineering methods and tools.
    Gernaey KV; Cervera-Padrell AE; Woodley JM
    Future Med Chem; 2012 Jul; 4(11):1371-4. PubMed ID: 22857525
    [No Abstract]   [Full Text] [Related]  

  • 38. An interview with Richard M. Eglen, Ph.D.
    Eglen RM
    Assay Drug Dev Technol; 2006 Oct; 4(5):503-9. PubMed ID: 17115921
    [No Abstract]   [Full Text] [Related]  

  • 39. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enantioselective chromatography in drug discovery.
    Zhang Y; Wu DR; Wang-Iverson DB; Tymiak AA
    Drug Discov Today; 2005 Apr; 10(8):571-7. PubMed ID: 15837600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.